Literature DB >> 11668620

Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.

C Ruiz-Ponte1, A Vega, A Carracedo, F Barros.   

Abstract

Germline mutations in the tumor-suppresor APC gene are associated with hereditary familial adenomatous polyposis (FAP) and somatic mutations are common in sporadic colorectal cancer. In this study, we report the identification of three novel germline mutations: 1682-1683insA, 3252-3253insAT, 3544A>T and a new somatic mutation 4130-4131delTT, all giving rise to truncated APC proteins. The majority of the mutations we found originate a truncated APC protein and cause the FAP phenotype. However, special attention must be given to the missense mutations Asp1822Val and Ser2621Cys since their segregation with the FAP phenotype is questionable. In our FAP families we did not find any genetical alterations at codon 1309, being this mutation the most frequent reported in APC. Differences in the recurrence of pathological mutations in APC could exist among populations. However, epidemiological studies must be performed to confirm this hypothesis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668620     DOI: 10.1002/humu.1198

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  15 in total

1.  A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells.

Authors:  Huanhuan Joyce Chen; Paula Miller; Michael L Shuler
Journal:  Lab Chip       Date:  2018-07-10       Impact factor: 6.799

2.  APC gene deletions in gastric adenocarcinomas in a Chinese population: a correlation with tumour progression.

Authors:  Zhengyu Fang; Yi Xiong; Jiana Li; Li Liu; Wei Zhang; Chao Zhang; Jun Wan
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

3.  Detection of APC gene deletions in colorectal malignancies using quantitative PCR in a Chinese population.

Authors:  Zhengyu Fang; Yi Xiong; Jiana Li; Li Liu; Manhui Li; Wei Zhang; Lei Shi; Jun Wan
Journal:  Pathol Oncol Res       Date:  2011-02-26       Impact factor: 3.201

4.  Mutation analysis of the APC gene in unrelated Korean patients with FAP: four novel mutations with unusual phenotype.

Authors:  Sung-Hee Han; Jae-Song Ryu; Young-Jin Kim; Han-Ik Cho; Young-Ho Yang; Kyoung-Ryul Lee
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

5.  Germline Missense Changes in the APC Gene and Their Relationship to Disease.

Authors:  Rodney J Scott; Renee Crooks; Lindy Rose; John Attia; Ammarin Thakkinstian; Lesley Thomas; Allan D Spigelman; Cliff J Meldrum
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

6.  Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients.

Authors:  Waltraut Friedl; Stefan Aretz
Journal:  Hered Cancer Clin Pract       Date:  2005-09-15       Impact factor: 2.857

7.  Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families.

Authors:  J M Chiang; H W Chen; R P Tang; J S Chen; C R Changchien; P S Hsieh; J Y Wang
Journal:  Fam Cancer       Date:  2009-09-19       Impact factor: 2.375

8.  Hereditary neoplasia syndromes and the role of the surgeon.

Authors:  Lisa C Coviello; Robert A Wascher
Journal:  Fam Cancer       Date:  2007-07-24       Impact factor: 2.375

9.  Recurrent APC gene mutations in Polish FAP families.

Authors:  Andrzej Pławski; Marta Podralska; Ryszard Słomski
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

10.  Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations?

Authors:  Nuria Gómez-Fernández; Sergi Castellví-Bel; Ceres Fernández-Rozadilla; Francesc Balaguer; Jenifer Muñoz; Irene Madrigal; Montserrat Milà; Begoña Graña; Ana Vega; Antoni Castells; Angel Carracedo; Clara Ruiz-Ponte
Journal:  BMC Med Genet       Date:  2009-06-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.